Clorox Stock Rides An 11-Day Winning Streak To A 25% Gain
Clorox (CLX) stock has risen for 11 consecutive trading days, gaining 25.2% over that stretch. That added about $2.7 billion to the company’s market value, which now stands at about $13.4 billion. The stock closed at $110.17 on Monday, November 16, 10.0% below its 52-week high of $122.35 and 39.0% above its low of $79.26.

The Streak Next To The S&P 500
Returns for CLX and the S&P 500 over the streak and the periods around it, all ending Monday, November 16 and including dividends:
| Return Period | CLX | S&P 500 |
|---|---|---|
| 1 Day | 0.6% | -1.9% |
| 11 Days (Current Streak) | 25.2% | -2.1% |
| 1 Month (21 Trading Days) | 28.3% | -3.1% |
| 3 Months (63 Trading Days) | 5.9% | -3.3% |
| Year To Date | 14.8% | 9.4% |
| 1 Year (252 Trading Days) | 11.0% | 11.4% |
How The Streak Compares With The Market
The market explains little of this: the S&P 500 lost 2.1% over the same 11 sessions, including dividends, against Clorox’s +25.2%. No other S&P 500 stock is currently on a winning streak of 11 days or longer. Over the past three months the stock is up 5.9%, a window that includes the streak; over the other 52 sessions of that window it was down 15.4%.
Do The Fundamentals Support The Run?
On the fundamentals, revenue grew 6.3% over the last twelve months, against a median of 5.4% for S&P 500 Consumer Staples stocks; its operating margin is 14.1%, versus a median of 14.5%; and the stock trades at 19.8 times trailing earnings against a median of 23.1. The read is mixed: revenue growth above the median and a multiple below the median on one side, margins below the median on the other.
A climb like this is worth respecting, and worth testing. Our Guidance Momentum screen tracks the stocks whose companies just raised their own forward numbers.
One Hot Stock Is A Story. Thirty Sound Ones Are A Strategy
A streak like this earns a place on your watchlist, and it also earns a question: how much of your outcome do you want depending on one company keeping this up?
The Trefis High Quality (HQ) Portfolio answers it with breadth: roughly 30 businesses picked for consistent cash generation, strong margins, and balance-sheet strength, sized and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Follow the story; invest in the strategy.